Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-based Parkinson's Disease Risk Assessment and Prognosis - Digital Biomarkers Development, Validation and Verification Study (AI-PROGNOSIS dBM-DEV Study)

NCT06444789 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06444789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06444789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-based Parkinson's Disease Risk Assessment and Prognosis - Digital Biomarkers Development, Validation and Verification Study (AI-PROGNOSIS dBM-DEV Study)
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Not yet recruiting
Start date
September 20, 2024
Completion date
July 15, 2025
Enrollment
90 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease